Inactivated influenza vaccines: Methods, policies, and politics

Journal of Clinical Epidemiology

Volumn 62, Issue 7, 2009, Pages 677-686

  Jefferson, T ^a   Di Pietrantonj, C ^a   Debalini, M G ^a   Rivetti, A ^a   Demicheli, V ^a  

^a ASL AL   (Italy)

Author keywords

Citation bias; Ethics; Influenza vaccines; Policy making; Trasparency

Indexed keywords

INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE;

ARTICLE; DIFFERENTIAL DIAGNOSIS; FLU LIKE SYNDROME; GERIATRIC CARE; HEALTH CARE POLICY; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MEDICAL LITERATURE; MORBIDITY; MORTALITY; POLITICS; PREGNANT WOMAN; PRIORITY JOURNAL; PUBLICATION;

EID: 67349279820     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2008.07.001     Document Type: Note

References (31)

1. WHO. Who position paper : influenza vaccines http://www.who.int/wer/2005/wer8033.pdf Accessed January 22, 2008).
2. Simonsen L., Taylor R.J., Viboud C., Miller M.A., and Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7 10 (2007) 658-666
3. Simonsen L., Reichert T.A., Viboud C., Blackwelder W.C., Taylor R.J., and Miller M.A. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165 3 (2005) 265-272
4. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., and Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35 2 (2006) 337-344
5. Jackson L.A., Nelson J.C., Benson P., Neuzil K.M., Reid R.J., Psaty B.M., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 35 2 (2006) 345-352
6. Pyhala R., Haanpaa M., Kleemola M., Tervahauta R., Visakorpi R., and Kinnunen L. Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match. Vaccine 19 (2001) 3253-3260
7. Feery B.J., Evered M.G., and Morrison E.I. Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. J Infect Dis 139 (1979) 237-241
8. Doshi P. Are US flu death figures more PR than science?. BMJ 331 (2005) 1412 10.1136/bmj.331.7529.1412
9. Simonsen L., Taylor R., Viboud C., Dushoff J., and Miller M. US flu mortality estimates are based on solid science. BMJ 332 (2006) 177-178 10.1136/bmj.332.7534.177-a
10. Nelson J.C., Jackson M.L., Weiss N.S., and Jackson L.A. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 62 (2009) 677-684
11. Jefferson T. The prevention of seasonal influenza-policy versus evidence. BMJ 333 (2006) 912-915
12. Jordan R., Connock M., Albon E., Fry-Smith A., Olowokure B., Hawker J., et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 24 (2006) 1047-1062
13. Smith S., Demicheli V., Di Pietrantonj C., Harnden A.R., Jefferson T., Matheson N.J., et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 1 (2006) 10.1002/14651858.CD004879.pub2 CD004879.pub2
14. Demicheli V., Rivetti D., Deeks J.J., and Jefferson T.O. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 3 (2004) 10.1002/14651858.CD001269.pub2 CD001269.pub2
15. Thomas R.E., Jefferson T., Demicheli V., and Rivetti D. Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst Rev 3 (2006) 10.1002/14651858.CD005187.pub2 CD005187.pub2
16. Rivetti D., Demicheli V., Di Pietrantonj C., Jefferson T.O., and Thomas R. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 3 (2006) 10.1002/14651858.CD004876 CD004876
17. Cates C.J., Jefferson T.O., Bara A.L., and Rowe B.H. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 4 (2003) 10.1002/14651858.CD000364.pub2 CD000364.pub2
18. Poole P.J., Chacko E., Wood-Baker R.W.B., and Cates C.J. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 1 (2006) 10.1002/14651858.CD002733.pub2 CD002733.pub2
19. UK Department of Health. The "Green Book." http://www.dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics/Gree nbook/DH_4097254 Accessed October 20, 2007).
20. Joint Committee on Vaccination and Immunisation. Annual report (2005/2006). http://www.advisorybodies.doh.gov.uk/JCVI/annualreport2005-06.pdf First accessed October 24, 2007.
21. Australia Government-Department of Health and Ageing. Australian immunisation handbook. 8th edition (2003). http://www9.health.gov.au/immhandbook/ Accessed October 17, 2007
22. Australia Government-Department of Health and Ageing. Australian immunisation handbook. 9th edition (2008). http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Conte nt/Handbook-home Accessed May 14, 2008
23. Centers for Disease Control and Prevention. Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2007 (2007) 1-54 56(No. RR-6)
24. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep 33 ACS-7 (2007 Jul 1) 1-38
25. Standing Vaccination Commission (STIKO). Recommendations of the Standing Vaccination Commission (STIKO) to the Robert Koch Institut. Epidemiol Bull 30 (2007) 267-286. http://www.rki.de/cln_048/nn_195844/DE/Content/Infekt/EpidBull/Archiv/20 07/30__07,templateId=raw,property=publicationFile.pdf/30_07.pdf Accessed November 6, 2007
26. Influenza RKI-Ratgeber Infektionskrankheiten-Merkblätter für Ärzte. (Recommendations of Robert Koch Institut (RKI), updated on February 2006). http://www.rki.de/cln_049/nn_200120/DE/Content/Infekt/EpidBull/Merkblaet ter/Ratgeber__Mbl__Influenza.html. Accessed November 6, 2007.
27. Standing Vaccination Commission (STIKO). Updated communication of the STIKO commission to RKI: Informations for physicians about the necessity to inform about unattended reactions following protective immunisations/status. Epidemiol Bull (2007) 219. http://www.rki.de/cln_048/nn_195850/DE/Content/Infekt/Impfen/Nebenwirkun gen/Anlagen/25__07,templateId=raw,property=publicationFile.pdf/25_07.pdf Accessed November 6, 2007
28. Standing Vaccination Commission (STIKO). Rationale for influenza immunisation recommendations of MS-patients with relapse episodes triggered through infections. http://www.rki.de/cln_048/nn_195848/DE/Content/Infekt/Impfen/STIKO__Empf ehlungen/Begruendung/influenza__ms,templateId=raw,property=publicationFi le.pdf/influenza_ms.pdf (Accessed November 6, 2007).
29. Standing Vaccination Commission (STIKO). The indication, "chronic pulmonary disease" for STIKO recommendation on influenza vaccination (and pneumococcus) includes also patients affected by bronchial asthma and COPD http://www.rki.de/cln_048/nn_195848/DE/Content/Infekt/Impfen/STIKO__Empf ehlungen/Begruendung/influenza__cl,templateId=raw,property=publicationFi le.pdf/influenza_cl.pdf. Accessed November 6, 2007.
30. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., and Levandowski R.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 123 (1995) 518-527
31. Jefferson T., Foxlee R., Del Mar C., Dooley L., Ferroni E., Hewak B., et al. Interventions for the interruption or reduction of the spread of respiratory viruses. Cochrane Database Syst Rev 4 (2007) 10.1002/14651858.CD006207.pub2 CD006207